Be Part of the Conversation by Joining Tweet Chat
The second day of CPhI Worldwide will host an industry wide tweet chat broadcasting a conversation between the CPhI expert panelists and the attendees.
The second day of CPhI Worldwide will host an industry wide tweet chat #CPhIChat broadcasting a conversation between the CPhI expert panelists and the attendees.
With the release of the CPhI 2015 annual report, attendees will be able to analyze the contributions of the panelists and contribute to a live discussion displayed throughout the screens at the show.
#CPhIChat will take place on Wednesday 14 October, from 2 to 4 pm. The entire industry is encouraged to log into Twitter to join the debate by using the hashtags #CPhIChat and #CPhIWW.
Attendees can follow the debate in real-time on the display screens that will be set-up throughout the exhibition. Alternatively, the debate can be followed by searching for the hashtags on Twitter from anywhere in the world. A summary report will be released after the show.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
